Risk of Acute Kidney Injury After Intravenous Contrast Media Administration

Study objective The study objective was to determine whether intravenous contrast administration for computed tomography (CT) is independently associated with increased risk for acute kidney injury and adverse clinical outcomes. Methods This single‐center retrospective cohort analysis was performed in a large, urban, academic emergency department with an average census of 62,179 visits per year; 17,934 ED visits for patients who underwent contrast‐enhanced, unenhanced, or no CT during a 5‐year period (2009 to 2014) were included. The intervention was CT scan with or without intravenous contrast administration. The primary outcome was incidence of acute kidney injury. Secondary outcomes included new chronic kidney disease, dialysis, and renal transplantation at 6 months. Logistic regression modeling and between‐groups odds ratios with and without propensity‐score matching were used to test for an independent association between contrast administration and primary and secondary outcomes. Treatment decisions, including administration of contrast and intravenous fluids, were examined. Results Rates of acute kidney injury were similar among all groups. Contrast administration was not associated with increased incidence of acute kidney injury (contrast‐induced nephropathy criteria odds ratio=0.96, 95% confidence interval 0.85 to 1.08; and Acute Kidney Injury Network/Kidney Disease Improving Global Outcomes criteria odds ratio=1.00, 95% confidence interval 0.87 to 1.16). This was true in all subgroup analyses regardless of baseline renal function and whether comparisons were made directly or after propensity matching. Contrast administration was not associated with increased incidence of chronic kidney disease, dialysis, or renal transplant at 6 months. Clinicians were less likely to prescribe contrast to patients with decreased renal function and more likely to prescribe intravenous fluids if contrast was administered. Conclusion In the largest well‐controlled study of acute kidney injury following contrast administration in the ED to date, intravenous contrast was not associated with an increased frequency of acute kidney injury.

[1]  R. Sinert,et al.  Does the current definition of contrast-induced acute kidney injury reflect a true clinical entity? , 2012, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.

[2]  David Y. Kho,et al.  Frequency of serum creatinine changes in the absence of iodinated contrast material: implications for studies of contrast nephrotoxicity. , 2008, AJR. American journal of roentgenology.

[3]  R. Hartman,et al.  Intravenous contrast material exposure is not an independent risk factor for dialysis or mortality. , 2014, Radiology.

[4]  D. Kallmes,et al.  Frequency of acute kidney injury following intravenous contrast medium administration: a systematic review and meta-analysis. , 2013, Radiology.

[5]  J. Newhouse,et al.  Risk of nephropathy after intravenous administration of contrast material: a critical literature analysis. , 2006, Radiology.

[6]  G. Stone,et al.  A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. , 2004, Journal of the American College of Cardiology.

[7]  J. Kline,et al.  Contrast nephropathy following computed tomography angiography of the chest for pulmonary embolism in the emergency department , 2007, Journal of thrombosis and haemostasis : JTH.

[8]  R. Solomon,et al.  Contrast-medium-induced acute renal failure. , 1998, Kidney international.

[9]  C. Schmid,et al.  A new equation to estimate glomerular filtration rate. , 2009, Annals of internal medicine.

[10]  J. Cohen,et al.  Hospital-acquired renal insufficiency: a prospective study. , 1983, The American journal of medicine.

[11]  J. Kline,et al.  Incidence of contrast-induced nephropathy after contrast-enhanced computed tomography in the outpatient setting. , 2010, Clinical journal of the American Society of Nephrology : CJASN.

[12]  R. Katzberg,et al.  Contrast-induced nephrotoxicity: clinical landscape. , 2006, Kidney international. Supplement.

[13]  H D Humes,et al.  Drug-induced nephrotoxicity. , 1982, Disease-a-month : DM.

[14]  R. Mehran,et al.  Contrast-induced nephropathy: definition, epidemiology, and patients at risk. , 2006, Kidney international. Supplement.

[15]  R. Schräder Contrast material-induced renal failure: an overview. , 2005, Journal of interventional cardiology.

[16]  C. Steiner,et al.  Comorbidity measures for use with administrative data. , 1998, Medical care.

[17]  C. Becker,et al.  Epidemiology and prognostic implications of contrast-induced nephropathy. , 2006, The American journal of cardiology.

[18]  Norbert Lameire,et al.  Notice , 2012, Kidney International Supplements.

[19]  J. Kline,et al.  Prospective study of the incidence of contrast-induced nephropathy among patients evaluated for pulmonary embolism by contrast-enhanced computed tomography. , 2012, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.

[20]  J. Tumlin,et al.  Economic burden of contrast-induced nephropathy: implications for prevention strategies , 2007, Journal of medical economics.

[21]  A. Roos,et al.  Incidence and predictors of contrast‐induced nephropathy following CT‐angiography for clinically suspected acute pulmonary embolism , 2010, Journal of thrombosis and haemostasis : JTH.

[22]  J. Kline,et al.  Major Adverse Events One Year After Acute Kidney Injury After Contrast-Enhanced Computed Tomography. , 2015, Annals of emergency medicine.

[23]  J. Bida,et al.  Intravenous contrast material-induced nephropathy: causal or coincident phenomenon? , 2013, Radiology.

[24]  A. Garg,et al.  The prognostic importance of a small acute decrement in kidney function in hospitalized patients: a systematic review and meta-analysis. , 2007, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[25]  A. Khwaja KDIGO Clinical Practice Guidelines for Acute Kidney Injury , 2012, Nephron Clinical Practice.

[26]  J. Ellis,et al.  Contrast material-induced nephrotoxicity and intravenous low-osmolality iodinated contrast material: risk stratification by using estimated glomerular filtration rate. , 2013, Radiology.

[27]  Patrick D. Brophy,et al.  KDOQI US commentary on the 2012 KDIGO (Kidney Disease: Improving Global Outcomes) clinical practice guideline for acute kidney injury , 2013 .

[28]  John A Kellum,et al.  Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury , 2007, Critical care.

[29]  S. Hou,et al.  Hospital-acquired renal insufficiency. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[30]  Marino Labinaz,et al.  Contrast-induced nephropathy and long-term adverse events: cause and effect? , 2009, Clinical journal of the American Society of Nephrology : CJASN.

[31]  D. Kallmes,et al.  Risk of intravenous contrast material-mediated acute kidney injury: a propensity score-matched study stratified by baseline-estimated glomerular filtration rate. , 2014, Radiology.